Project Grant R01DA065545
Award Date 4/15/26
Completion Date 2/28/31
Dollars Obligated $582K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
- Federal Project Grant Award Summary Columbia University received a $246,012 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through June 30, 2028. The award funds development and evaluation of a digital crowdsourced intervention designed to increase HIV, STI (sexually transmitted infection), and HCV (hepatitis C virus) testing uptake and substance use service utilization among...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $344,214 Project Grant effective June 23, 2025, through December 31, 2027, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research project investigates the combined role of nicotine and the NLRP3 inflammasome in HIV-1-associated central nervous system (CNS) inflammation, with the objective of elucidating mechanisms underlying neuroinflammation and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $431,643 under its Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (SUNY at Binghamton) on August 1, 2025, for a two-year project concluding July 31, 2027. This Project Grant funds the development and pilot testing of a telehealth-delivered, pain-targeted motivational smoking intervention designed for smokers with chronic pain who are not ready to...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded $109,652 to the University of Miami's Office of Research Administration on August 19, 2026, for an implementation research study examining telehealth delivery models for HIV and substance use disorder (SUD) care among people who inject drugs (PWID). This one-year project, scheduled for completion by August 18, 2027, will produce research...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UCLA a $188,199 Project Grant effective April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a digital therapeutic intervention for individuals with comorbid anxiety disorders and alcohol or cannabis use disorders. The primary deliverable is a mobile application-based intervention titled Anxiety Management Treatment for Substance Use Disorders (AMT/SUD), which...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Biomotivate LLC a $613,744 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support emotional regulation and resilience in individuals with opioid use disorders (OUDs). The platform combines generative artificial intelligence, predictive analytics,...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC Berkeley a $1.6M Project Grant effective September 1, 2025, through May 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a web-based behavioral intervention for smoking cessation. The primary deliverable is research evaluating the efficacy and mechanisms of Regulation of Craving Training (ROC-T), a brief, digital intervention designed to enhance smokers'...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $784,528 to The Miriam Hospital under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, and concluding April 30, 2030. This research initiative investigates the effects of endogenous and exogenous ovarian hormones on electronic nicotine delivery systems (ENDS) use, addressing the public health epidemic of ENDS consumption among young adults, particularly women....
- Federal Grant Award Summary The National Institute on Drug Abuse awarded J. David Gladstone Institutes a $1,343,271 Project Grant (CFDA 93.279, Drug Use and Addiction Research Programs) effective May 15, 2025, through March 31, 2030, to develop targeted small molecule recruitment strategies for suppressing the HIV transcriptionally active reservoir in individuals with substance use disorder (SUD). The research addresses a critical gap in antiretroviral therapy (ART), which fails to target latent...